Some of the leading players operating in the adhesion barrier market include
Johnson & Johnson
Baxter International
Leader Biomedical
Anika Therapeutics
Atrium Medical Corporation
Becton Dickinson and Company
Integra LifeSciences Holdings Corporation
Authors:
Mariam Faizullabhoy
Frequently Asked Questions (FAQ) :
Global Adhesion Barrier Industry was worth more than USD 785.4 million in 2023 and is projected to reach around USD 1.35 billion by 2032 driven by the increasing number of invasive surgeries and rising awareness about adhesion-related diseases.
The synthetic adhesion barriers segment amassed around USD 366.4 million in 2022 and is estimated to grow at a robust pace through 2032 owing to the availability of innovative products specific to the synthetic category, including hyaluronic acid and regenerated cellulose, among others.
The North America adhesion barrier industry held a sizable share and is expected to reach around USD 493.5 million by the end of 2032 attributed to the presence of a significant patient pool related to different diseases.
Johnson & Johnson, Baxter International, Leader Biomedical, Anika Therapeutics, Atrium Medical Corporation, Becton Dickinson and Company, and Integra LifeSciences Holdings Corporation, among others are some notable enterprises engaged in the market.